CTOs on the Move


 
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.elekta.com
  • 400 Perimeter Center Terrace Suite 50
    Atlanta, GA USA 30346
  • Phone: 770.300.9725

Executives

Name Title Contact Details
John Lapré
Chief Technology Officer Profile

Similar Companies

Liberty Drug and Surgical

Liberty Drug and Surgical is a Chatham, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Texas Physical Therapy Specialists P.C

Texas Physical Therapy Specialists P.C is a New Braunfels, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kestra Medical Technologies

Kestra Medical Technologies is a venture backed, medical device start up company located in Washington State providing innovative, intuitive medical technologies to protect and support at-risk patients.

First Biomedical

First Biomedical is a Olathe, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bardy Diagnostics

Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM™ can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Developed on the principle that non-invasive cardiac monitoring should provide an excellent quality atrial signal, the CAM is designed to be placed along the sternum—over the heart— to optimize P-wave signal capture. The result is improved ECG resolution, providing more information about the heart rhythm which may lead to more clinically actionable diagnoses.